3
Views
0
CrossRef citations to date
0
Altmetric
METRONIDAZOLE

Parenteral metronidazole

Its use in serious anaerobic infections

Pages 115-118 | Published online: 07 Jul 2016

References

  • Powell SJ, MacLeod I, Wilmot AJ, et al. Metronictazole in amoebic dysentery and amoebic liver abscess. Lancet 1966: 2: 1329–31
  • Rhambatta RB. Metronidazole in giardiasis. Ann Trop Med Parasitol 1971: 65: 487–9
  • Pheifer TA. Forsyth PS, Durfee MA. et al. Nonspecific vaginitis: role of Haemophilus maginalis and treatment with metronidazole. N Engl J Med 1978: 298: 1429–34
  • Balsdon MJ, Taylor GE, Pead L, et al. Corynebacterium vaginale and vagonitis: a controlled trial of treatment. Lancet 1980: 1: 501–3
  • Davies AH, McFadzean JA. Squires S. Treatment of Vincent's stomatitis with metronidazole. Br Med J 1964: 5391: 1149–50
  • Ueno K, Ninomiya K. Suzuki S. Antibacterial activity of metronidazole against anaerobic bacteria. Chemotherapy 1971: 19: 111–4
  • Tally FP, Sutter VL, Finegold SM. Metronidazole versus anaerobes: in vitro data and initial clinical observations. Calif Med 1972: 117: 22–6
  • Nastro LJ, Finegold SM. Bactericidal activity of five antimicrobial agents against Bacteroides fragills. J Infect Dis 1972: 126: 104–7
  • LaRuaso NF, Tomaaz M, Muller M, et al. Interaction of metronidazole with nucleic acids in vitro. Mol Pharmacol 1977: 13: 872–82
  • Knight RC, Skolimowski IM. Edwarda DI. The Interaction of reduced metronidazole with DNA Biochem Pharmacol 1978: 27: 2089–93
  • McGlliveray IJ, Midha KK. Loo JC, et al. The bioavailability of commercial metronidazole formulation. Int J Clin Pharmacol Ther Toxicol 1978: 16: 110–5
  • Cerat GA. McHenry MC, Wagner JG, et al. Metronidazole in renal failure. New York: Elsevier North Holland (Excerpta Medica). 1976: 404–14 (publication No. 4381
  • Gabriel R. The pharmacokinetics of metronidazole in patients whth chronic renal failure. In: Phillips I. Collier J. eds. Metronidazole. Vol 18. Royal Society of Medicine International Congress and Symposium Series. New York: Gnme & Stratton. (Academic Press). 1979: 49–54
  • Chow AW, Patten V, Guze LB, et al. Susceptibilty of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive bacilli. J Infect Dis 1975: 131: 182–5
  • Brogden RN, Heel RC, Speight TM, et al. Metronidazole in anaerobic infections: a review of its activity. pharmacokinetics and therapeutic use. Drugs 1978: 16: 387–417
  • Rissing JP, Moor WL, et al. Treatment of anaerobic infections with metronidazole. Curr Ther Res 1980: 27: 651–63
  • Giamarellou H, Kanellakopoulou K. Pragastis D, et al. Treatment with metronidazole of 48 patients with Serious anaerobic infection. J Antimicrob Chemother 1977: 3: 347–53
  • Galgiani JN, Busch DF, Brasa C, et al. Bacteroi des fraqilis endocarditis. baeteremia and other infections treated with oral or intravenous metronidazole. Am J Med 1978: 65: 284–9
  • Warner JF, Perkins RL, Cordero L. Metronidazole therapy of anaerobic bacteremia. meningitis. And brain absess. Arch intern Med 1979: 139: 167–9
  • Eykyn SJ, Phillips I. Metronidazole in surgical infections. J Antimicrob Chemother 1978: 4(Suppl C): 75–81
  • Onderdonk AB, Louie TJ, Tally FP, et al. Activity of metronidazole against Escherichia coli in experimental Intra-abdominal sepsis. J Antimicrob Chemother 1979: 5: 201–10
  • Ralph ED, Kirby WM. Human pharmacology of oral metronidazole as determined by bioassay. New York: Elsevier North-Holland (Excerpta Medica). 1977: 50–7
  • Rissing JP, Newman C, Moore WL Jr. Artifactual depression of serum glutamic oxaloacetic transaminase by metronldazole. Antimicrob Agents Chemother 1978: 14: 636–8
  • Roe JF. A critical appraisal of the toxiclolgy of metronidazole. In: Phillips I. Collier J. eds. Metronidazole. New York: Grune & Stration (Academic Press). 1980: 219–22
  • Kazmier FJ. A significant interaction between metronidazole and warfarin. Mayo Clin Proc. 1976: 51: 782–4
  • Rustia M, Shubik P. Experimental induction of hepatomas. mammary tumors. and other tumors with metronidazole in non inbred Sas: MRC(WI)BR rats. J NCI 1979: 3: 863–8
  • Rosenkranz HS, Speck WT. Mutagenicity of metronidazole: activation by mammalian liver microsomes. Biochem Biophys Res Commun 1975: 66: 520–5
  • McCann J, Ames BN. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals—discussion. Proc Natl Acad sci USA 1976: 73: 950–4
  • Beard CM, Noller KL, O'Fallon WM, et al. lack of evidence for cancer due to use of mrtronidazole. N Engl J Med 1979: 301: 519–22
  • Friedman GD. Cancer after metronidazole. (Letter) N Engl J Med 1980: 302: 519

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.